Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank

Background: New biomarkers are urgently needed to facilitate diagnosis in Interstitial Lung Diseases (ILD), thus reducing the need for invasive procedures, and to enable tailoring and monitoring of medical treatment. Methods: In this study we investigated if patients with idiopathic pulmonary fibros...

Descripción completa

Detalles Bibliográficos
Autores principales: Krauss, Ekaterina, Froehler, Maike, Degen, Maria, Mahavadi, Poornima, Dartsch, Ruth C., Korfei, Martina, Ruppert, Clemens, Seeger, Werner, Guenther, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572439/
https://www.ncbi.nlm.nih.gov/pubmed/31075945
http://dx.doi.org/10.3390/jcm8050643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572439/
https://www.ncbi.nlm.nih.gov/pubmed/31075945
http://dx.doi.org/10.3390/jcm8050643

Ejemplares similares